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Moderate alcohol consumption is associated with a reduced risk of cardiovascular disease. Data on alcohol
consumption and atherosclerosis are scarce. To determine the association between alcohol consumption and
risk of peripheral arterial disease, the authors carried out a cross-sectional study (1990–1993) in the population-
based Rotterdam Study among men and women aged 55 years or over. Data on alcohol consumption and
peripheral arterial disease, as measured by the ankle/brachial blood pressure index, were available for 3,975
participants without symptomatic cardiovascular disease. Male drinkers consumed beer, wine, and liquor, while
female drinkers consumed predominantly wine and fortified wine types. An inverse relation between moderate
alcohol consumption and peripheral arterial disease was found in women but not in men. Because of residual
confounding by smoking, analyses were repeated in nonsmokers. In nonsmoking men, odds ratios were 0.86
(95% confidence interval (CI): 0.46, 1.63) for daily alcohol consumption up to and including 10 g, 0.75 (95% CI:
0.37, 1.55) for 11–20 g, and 0.68 (95% CI: 0.35, 1.34) for more than 20 g, compared with nondrinking. In
nonsmoking women, corresponding odds ratios were 0.65 (95% CI: 0.48, 0.87), 0.66 (95% CI: 0.42, 1.05), and
0.41 (95% CI: 0.21, 0.77), respectively. In conclusion, an inverse association between alcohol consumption and
peripheral arterial disease was found in nonsmoking men and women. Am J Epidemiol 2002;155:332–8.
aged; alcohol drinking; alcoholic beverages; atherosclerosis
Received for publication August 28, 2000, and accepted for pub-
lication August 20, 2001.
Abbreviations: CI, confidence interval; OR, odds ratio.
1 Department of Epidemiology and Biostatistics, Erasmus
University Medical School, Rotterdam, the Netherlands.
2 Department of Radiology, State University Groningen/University
Hospital Groningen, Groningen, the Netherlands.
3 Department of Human Nutrition and Epidemiology, Agricultural
University, Wageningen, the Netherlands.
4 Julius Center for Patient Oriented Research, University Medical
Center, Utrecht, the Netherlands.
Correspondence to Dr. J. C. M. Witteman, Department of
Epidemiology and Biostatistics, Erasmus University Medical School,
P.O. Box 1738, 3000 DR Rotterdam, the Netherlands (e-mail: witte-
man@epib.fgg.eur.nl).
Alcohol drinking affects the occurrence of ischemic heart
disease. The association of alcohol with coronary morbidity
and mortality is U or J shaped (1–5). The underlying mecha-
nism of the reduced risk associated with moderate levels of
alcohol is not known. One of the potential mechanisms is the
effect of alcohol on atherosclerosis (3). The presence of
peripheral arterial disease, which is largely asymptomatic, is
an indicator of a long-term atherogenic process in the periph-
eral blood vessels. Peripheral arterial disease is considered
present below a certain cutoff point of the ankle/brachial
blood pressure index (6), and it is associated with athero-
sclerotic diseases in other vessel beds (7) and with cardio-
vascular morbidity and mortality (8–12). Only a few studies
have investigated the relation between alcohol consumption
and peripheral arterial disease. Among the 1,592 participants
of the Edinburgh Artery Study, a positive linear association
of alcohol consumption with the ankle/brachial blood pres-
sure index was found in men but not in women (13). The pro-
tective effect was attributable to wine drinking in particular,
but it was no longer significant after additional adjustment
for social class. A recent study in 4,549 American Indian men
and women showed a significant inverse association of alco-
hol consumption with peripheral arterial disease (14).
However, the level of alcohol intake and the type of bever-
ages consumed were not taken into account. The prospective
Physicians’ Health Study demonstrated an inverse associa-
tion of moderate alcohol use with symptomatic peripheral
arterial disease (15), although the range of alcohol intake in
the study population was small and this population com-
prised relatively healthy men. In the Framingham Heart
Study an inverse association was found between moderate
alcohol consumption and the occurrence of intermittent clau-
dication (16). However, only a small proportion of subjects
with peripheral arterial disease were symptomatic.
Furthermore, alcohol might have influenced the clinical
symptoms of peripheral arterial disease (17).
The population-based Rotterdam Study of 7,983 people
aged 55 years or over provides the opportunity to investi-
gate in detail the association of alcohol consumption with
peripheral arterial disease. In 3,975 subjects free from car-
diovascular disease at baseline, we studied the consump-
tion of different levels and types of alcohol in relation to
peripheral arterial disease, taking into account important
confounders.
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MATERIALS AND METHODS
The Rotterdam Study
The Rotterdam Study is a prospective study designed to
investigate the occurrence and determinants of chronic and
disabling cardiovascular, neurogeriatric, locomotor, and
ophthalmologic diseases in an aging population. The ratio-
nale and design of the study have been described previously
(18). The cohort includes 7,983 men and women aged 55
years or over (78 percent of the eligible population), living
in a suburb of Rotterdam, the Netherlands. Of these, 879
subjects lived in nursing homes. From August 1990 until
June 1993, baseline data were collected during a home inter-
view by a trained research assistant and at two visits to the
study center for clinical examination and assessment of diet.
Assessment of alcohol intake and diet
Alcohol consumption was assessed as part of a dietary
interview. A trained dietician interviewed the participants at
the study center, using a validated, semiquantitative food
frequency questionnaire (19). The interview was based on a
checklist on which the subjects had indicated the foods and
beverages consumed more than once a month during the
preceding year. The dietary interviews were performed
using a computer program that simultaneously checked the
data. Participants reported the number of alcoholic bever-
ages they consumed on a weekly basis, in each of four cate-
gories: beer, wine, liquor, and moderately strong alcohol
types. The latter category contained predominantly fortified
wines, namely, sherry and port. Nondrinkers were consid-
ered abstainers. The subjects were asked whether their level
of alcohol use had changed during the last 5 years and, if so,
whether the amount had increased or decreased. For each of
the different beverages, the number of drinks was multiplied
by the average amount of ethanol in one drink of the alco-
holic beverage. A “drink” was defined as 200 ml of beer that
contained 8.0 g of ethanol, 100 ml of wine that contained
10.0 g of ethanol, 50 ml of liquor that contained 14.0 g of
ethanol, or 75 ml of moderately strong alcohol types that
contained 10.5 g of ethanol. By adding the amounts of
ethanol in the four groups, we calculated the total amount of
alcohol in grams per day. A validation study that compared
the nutrient intake derived from the food frequency ques-
tionnaire with that from a 15-day food record showed a cor-
relation coefficient of 0.89 for the intake of alcohol (19).
Because most of the moderately strong alcoholic drinks
were wine types, this category was combined with the wine
category in the analyses. The alcohol consumption was
divided into nondrinking, use of ≤10 g, >10–≤20 g, and >20
g/day.
Study interview
Smoking status was assessed, and subjects were catego-
rized as current, former, or never smokers. In ever smokers,
we asked for the average number of cigarettes smoked, as
well as the number of smoking years. From this information,
the number of cigarette pack-years was computed. We used
information about the highest attained level of education as
an indicator of socioeconomic status. This variable was cat-
egorized as low (primary education), intermediate (sec-
ondary general or vocational education), and higher (higher
vocational education or university). Intermittent claudica-
tion was diagnosed according to the criteria of the World
Health Organization by means of the Rose questionnaire
(20). Information on myocardial infarction and stroke in the
subjects’ history was obtained by direct questioning and
considered positive when confirmed by physicians’ records.
Data on previous coronary artery bypass graft surgery or
percutaneous transluminal coronary angiography were col-
lected during the interview.
Clinical examination
Clinical examinations were performed during a visit at
the research center. Height and weight were measured with
participants in light clothes and without shoes. Body mass
index was calculated as the weight (kg)/height (m)2. Serum
total cholesterol was determined by an enzymatic proce-
dure. High density lipoprotein cholesterol was measured
similarly after precipitation of the non-high density lipopro-
tein cholesterol fraction (21). Diabetes mellitus was consid-
ered present with current use of antidiabetes medication, or
when nonfasting random or postload glucose levels
exceeded 11.0 mmol/liter (22, 23).
Blood pressure was measured at the right brachial artery
using a random-zero sphygmomanometer with the partici-
pant in a sitting position. The mean of two consecutive mea-
surements was used in the analysis. Hypertension was
defined as a systolic blood pressure of 160 mmHg or higher,
a diastolic blood pressure of 95 mmHg or higher, or current
use of antihypertensive drugs for the indication of hyperten-
sion. An 8-MHz continuous wave Doppler probe (Huntleigh
500 D; Huntleigh Technology, Bedfordshire, United
Kingdom) and a random-zero sphygmomanometer were
used to measure the systolic blood pressure level of the pos-
terior tibial artery in both legs (6). The blood pressure was
measured once for each leg, with the participant in supine
position. The ratio of the ankle systolic blood pressure to the
brachial systolic blood pressure, the ankle/brachial blood
pressure index, was calculated for each leg. Peripheral arte-
rial disease was considered present when the ankle/brachial
index was <0.9 in at least one leg (24).
Population for analysis
Noninstitutionalized participants who visited the study
center were eligible for a dietary interview (n  6,521). Of
these, diet could not be assessed in 271 subjects of the pilot
phase and in 122 subjects suspected of dementia.
Furthermore, a random group of 481 participants was not
interviewed because of logistic reasons. Of the dietary
reports, 212 were considered unreliable by the dietician and
were excluded. Thus, dietary data were available for 5,435
subjects. Of these 5,435, data on the ankle/brachial blood
pressure index were missing for 535 participants.
Additionally, subjects with an ankle/brachial blood pressure
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index of more than 1.5 (n  272) were excluded because this
index usually results from arterial rigidity that prevents com-
pression of the ankle artery. Subjects with complete data on
diet and the ankle/brachial blood pressure index (n  4,900)
differed from excluded subjects (n  1,621) only in mean age
and in diabetes status. The mean age was higher in those
excluded because of exclusion of subjects suspected for
dementia, while the percentage of diabetes mellitus was
higher in subjects excluded because of missing data, probably
from nonassessable arteries on both sides. To avoid a spurious
association due to a change in alcohol consumption as a result
of symptomatic cardiovascular disease, subjects with a his-
tory of myocardial infarction, stroke, coronary artery bypass
graft surgery, or percutaneous transluminal coronary angiog-
raphy were excluded from the analysis (n  653). Ultimately,
3,975 subjects were included in the present analysis.
Data analysis
Levels of potential confounders were compared between
categories of alcohol consumption, using a general linear
model. In this model, age and sex were included as covari-
ates. Risk estimates were obtained for men and women sep-
arately. The relation between alcohol consumption and
peripheral arterial disease was assessed using logistic
regression analysis that adjusted for age. The risk of periph-
eral arterial disease in each category of alcohol consumption
was compared with the risk among nondrinkers. The associ-
ations were expressed as odds ratios with 95 percent confi-
dence intervals. A second model additionally adjusted for
possible confounding factors, namely, cigarette pack-years,
body mass index, and diabetes mellitus. Another model also
adjusted for education as a measure of socioeconomic sta-
tus. The first two logistic models were also conducted after
exclusion of subjects who had reduced their alcohol con-
sumption in the last 5 years. Because of potential residual
confounding by smoking, we stratified according to smok-
ing status and repeated the logistic regression analysis,
adjusting for age and cigarette pack-years. To study the
association of drinking (yes/no) specific types of alcohol,
we used the two aforementioned logistic regression models
but simultaneously took into account the amount of con-
sumption of other types of alcohol. The data were analyzed
using SPSS 7.5 for Windows (SPSS, Inc., Chicago, Illinois).
RESULTS
General characteristics of the study population are pre-
sented in table 1. Of the participants, 62.5 percent were
female. The percentage of drinkers among men (88.5 per-
cent) was higher than that among women (74.7 percent).
Furthermore, the average daily amount of alcohol consumed
by drinkers was much higher for men than for women (16.4
(standard deviation, 18.8) g and 6.2 (standard deviation,
10.2) g, respectively). The prevalence of peripheral arterial
disease was slightly lower in men (13.4 percent) than in
women (14.4 percent). Of those with peripheral arterial dis-
ease, only a few subjects reported intermittent claudication
as assessed by the Rose questionnaire (7.5 percent of male
cases, 3.9 percent of female cases). In a general linear model
adjusted for sex, the mean level of alcohol intake decreased
with an increase in age category (p for trend < 0.001). After
TABLE 1. Baseline characteristics of 3,975 men and women aged 55 years or over without 
cardiovascular disease, The Rotterdam Study, 1990–1993*
Characteristics Men(n = 1,489)
Age (years)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Serum total cholesterol (mmol/liter)
Serum high density lipoprotein cholesterol (mmol/liter)
Body mass index (kg/m2)
Diabetes mellitus (%)
Smoking (%)
Current
Former
Never
Daily alcohol consumption (%)
Nondrinker
≤10 g
>10–≤20 g
>20 g
Ankle/brachial index
Peripheral arterial disease (%)
Intermittent claudication (%)
Educational level (%)
Low
Intermediate
Higher
66.5 (7.2)
139 (22)
75 (12)
6.3 (1.2)
1.23 (0.3)
25.7 (2.8)
8.1
30.1
61.9
9.0
11.5
37.3
19.1
32.1
1.11 (0.2)
13.4
1.4
20.7
58.2
21.1
67.4 (7.8)
139 (22)
73 (11)
6.8 (1.2)
1.46 (0.4)
26.6 (4.0)
8.8
19.2
28.6
52.2
25.3
51.6
12.7
10.4
1.07 (0.2)
14.4
0.9
40.4
52.8
6.8
Women
(n = 2,486)
* Values are means (standard deviation) or percentages.
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adjustment for age and sex, the level of alcohol intake was
associated with cigarette pack-years (p < 0.001), diabetes
mellitus (p  0.12), and attained level of education (p 
0.02) (data not shown). The level of high density lipoprotein
cholesterol was significantly higher in male and female
drinkers compared with nondrinkers. In addition, women
who consumed alcohol were on average older, more often
diabetic, more likely smokers, and more highly educated
compared with nondrinking women.
Table 2 shows the distribution of consumption of various
alcoholic beverages. Among men, beer, liquor, and wines
were consumed by almost equal percentages (46.6, 40.1,
and 41.4 percent, respectively). The average daily amount
consumed by drinkers of the specific beverages was higher
for beer and liquor (1.2 drinks) than for wine and fortified
wine (0.74 drink). The percentage of women who drank
wine and fortified wine was much higher (66.4 percent) than
the percentages of women who drank beer and liquor (5.2
and 17.5 percent, respectively). Wine-, beer-, or liquor-
drinking women drank less than men who drank the same
alcoholic beverages.
Table 3 presents odds ratios of peripheral arterial disease
for various levels of alcohol consumption adjusted for age
and in multivariate analyses additionally adjusted for ciga-
rette pack-years, body mass index, and diabetes mellitus. In
men, there was no inverse association between alcohol con-
sumption and the risk of peripheral arterial disease. In the
age-adjusted model, a slightly protective, but statistically
nonsignificant association with peripheral arterial disease
was observed for men who consumed up to 10 g of alcohol
daily compared with nondrinkers (odds ratio (OR)  0.84,
95 percent confidence interval (CI): 0.51, 1.38). However,
this association disappeared in multivariate analysis. In
women, a risk reduction of 22–36 percent was observed for
alcohol drinkers compared with nondrinkers. This reduced
risk among women was significant for daily consumption of
up to 10 g of alcohol and in multivariate analysis for up to
20 g of alcohol daily. Additional adjustment for socioeco-
nomic status did not change the results for either sex (data
not shown). There was no significant interaction between
alcohol consumption and sex (data not shown). Exclusion of
subjects who had reduced their alcohol consumption in the
last 5 years (190 subjects, 4.0 percent of the women and 6.1
percent of the men) did not affect the associations (data not
shown).
Stratified analysis according to smoking status revealed
different odds ratios of peripheral arterial disease by cate-
gory of alcohol consumption in smokers and nonsmokers
(table 4). In logistic regression analysis adjusted for age and
cigarette pack-years, odds ratios of peripheral arterial dis-
ease in increasing categories of alcohol consumption were
lower among past and never smokers than among current
smokers. In past and never smokers, an inverse association
was found between alcohol consumption and peripheral
arterial disease. In nonsmoking men, the odds ratios were
0.86 (95 percent CI: 0.46, 1.63) for daily alcohol consump-
tion up to 10 g, 0.75 (95 percent CI: 0.37, 1.55) for 11–20 g,
and 0.68 (95 percent CI: 0.35, 1.34) for more than 20 g com-
TABLE 2. Consumption of alcoholic beverages in 3,975 men and women without cardiovascular 
disease, The Rotterdam Study, 1990–1993
Beer Liquor
Men (n = 1,489)
Women (n = 2,486)
46.6
5.2
Wine and fortified wine
Beverage type
Drinkers
(%)
Drinks/day*
(SD†)
Drinkers
(%)
Drinkers
(%)
Drinks/day
(SD)
Drinks/day
(SD)
0.74 (0.9)
0.61 (0.8)
41.4
66.4
1.20 (1.3)
0.76 (1.0)
40.1
17.5
1.19 (1.7)
0.48 (0.7)
* Average number of drinks per day in drinkers.
† SD, standard deviation.
TABLE 3. Risk of peripheral arterial disease according to level of alcohol consumption among 3,975
men and women without cardiovascular disease, The Rotterdam Study, 1990–1993
Cases/controls
(no.)
Age-adjusted
odds ratio
95% confidence
interval
Multivariate-
adjusted
odds ratio†
95% confidence
interval
Men (n = 1,489)
Nondrinker
≤10 g
>10–≤20 g
>20 g
Women (n = 2,486)
Nondrinker
≤10 g
>10–≤20 g
>20 g
26/145
71/485
37/247
65/413
1.00
0.84
0.91
0.97
Reference
0.51, 1.38
0.52, 1.58
0.59, 1.61
1.00
0.97
1.02
0.97
Reference
0.58, 1.63
0.57, 1.80
0.57, 1.65
122/507
163/1,119
39/277
34/225
1.00
0.66**
0.69
0.78
Reference
0.51, 0.91
0.46, 1.02
0.51, 1.19
1.00
0.70*
0.66*
0.64
Reference
0.53, 0.91
0.43, 1.00
0.41, 1.01
Daily alcohol 
consumption
* p < 0.05; **p < 0.01.
† Multivariate analysis: additionally adjusted for cigarette pack-years, body mass index, and diabetes mellitus.
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pared with nondrinking (test for trend: p  0.21). In non-
smoking women, corresponding odds ratios were 0.65 (95
percent CI: 0.48, 0.87), 0.66 (95 percent CI: 0.42, 1.05), and
0.41 (95 percent CI: 0.21, 0.77), respectively (test for trend:
p < 0.001). The lowest odds ratio was found in never smok-
ing women with a daily alcohol consumption of more than
20 g (OR  0.32, 95 percent CI: 0.11, 0.91). In smoking
subjects there was no inverse association between alcohol
consumption and peripheral arterial disease.
The risk of peripheral arterial disease associated with the
use of the separate alcoholic beverages was computed,
adjusted for age and the use of other alcoholic beverages,
and in a second model adjusted also for cigarette pack-years,
body mass index, and diabetes mellitus. The association was
stronger for the consumption of wine and fortified wine than
for the consumption of beer or liquor. In women, the risk of
peripheral arterial disease associated with the use of wine
types was statistically significant (first model: OR  0.72,
95 percent CI: 0.57, 0.91; second model: OR  0.74, 95 per-
cent CI: 0.58, 0.95). In men, the odds ratios for wine were
0.81 (95 percent CI: 0.59, 1.13) and 0.88 (95 percent CI:
0.63, 1.24), respectively. The estimates of the risk of periph-
eral arterial disease associated with beer and liquor con-
sumption for both men and women ranged from 0.86 to 1.14
and were not statistically significant. In logistic regression
analysis of data from nonsmokers, no consistent association
between an alcoholic beverage and peripheral arterial dis-
ease was found, except for wine and fortified wine in
women (OR  0.67, 95 percent CI: 0.51, 0.88). There was
no significant inverse association between any type of alco-
holic beverage and peripheral arterial disease in current
smokers (odds ratios ranging from 0.92 to 1.17).
DISCUSSION
In the large population-based Rotterdam Study, we found
an inverse association of alcohol consumption with periph-
eral arterial disease in women. The association was present
already at low levels of alcohol use and was still present for
levels of moderate alcohol consumption. In men, there was
virtually no association of alcohol intake with peripheral
arterial disease. Among nonsmoking subjects, an inverse
association was found between alcohol consumption and
peripheral arterial disease in both men and women. The
largest risk reduction, 59 percent, was found in women who
consumed over 20 g of ethanol per day. The strengths of the
present study include a large and well-described cohort of
elderly men and women, classification of consumption of
alcohol and the types of beverages based on a validated food
checklist, and a relatively large number of mostly asympto-
matic peripheral arterial disease cases (558 subjects).
In the present study, drinking habits were self reported.
This might have caused underreporting of alcohol use, espe-
cially among heavy drinkers. This is more likely to have
occurred for men than for women, since more men were
heavy drinkers. Imprecision in the reporting of alcohol con-
sumption would tend to weaken the associations found.
Shaper et al. (4) have argued that nondrinkers might not be
suitable for use as reference group in an examination of the
effects of alcohol on peripheral arterial disease. The group
of nondrinkers could be less healthy than expected, because
of inclusion of former heavy drinkers and people who have
stopped drinking because of ill health, particularly ischemic
heart disease. Furthermore, it is probable that lifelong non-
drinkers have reasons for being abstainers that introduce
other biases and have an adverse risk profile. This is most
likely for men, for whom abstaining from alcohol is rather
uncommon in society, at least in the age category of our
cohort. However, additional exclusion of subjects who had
reduced their alcohol consumption in the last 5 years did not
change our results. Furthermore, participants with prevalent
symptomatic cardiovascular disease were excluded from the
analysis. In addition, drinking patterns may influence the
risk of cardiovascular diseases (25). In our study, there was
no information about the regularity of alcohol consumption.
Using peripheral arterial disease as an indicator of ather-
osclerosis has the advantage that most subjects with periph-
eral arterial disease are asymptomatic (6). Thus, spurious
associations between alcohol and peripheral arterial disease,
TABLE 4. Risk of peripheral arterial disease by level of alcohol consumption according to smoking 
status among 3,975 men and women without cardiovascular disease, The Rotterdam Study, 1990–1993
Cases/controls
(no.) Odds ratio
95% 
confidence
interval†
Cases/controls
(no.) Odds ratio
Men (n = 1,489)
Nondrinker
≤10 g
>10–≤20 g
>20 g
Women (n = 2,486)
Nondrinker
≤10 g
>10–≤20 g
>20 g
1.00
0.85
1.19
1.31
Reference
0.38, 2.00
0.49, 2.93
0.59, 2.91
16/103
45/360
20/182
28/287
1.00
0.86
0.75
0.68
Reference
0.46, 1.63
0.37, 1.55
0.35, 1.34
1.00
0.75
0.70
1.05
Reference
0.41, 1.39
0.32, 1.59
0.53, 2.08
100/430
130/943
28/215
12/151
1.00
0.65*
0.66
0.41*
Reference
0.48, 0.87
0.42, 1.05
0.21, 0.77
Daily alcohol 
consumption
* p < 0.01.
† Adjusted for age and cigarette pack-years.
Current smokers
95% 
confidence
interval†
Past or never smokers
10/42
26/125
17/65
37/126
22/77
33/176
11/62
22/74
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resulting from symptoms that cause a change in alcohol con-
sumption, are not likely to occur. Possible misclassification
of peripheral arterial disease cases was probably nondiffer-
ential and would only weaken the real associations. In the
Rotterdam Study, subjects did not report their physical
activity, one of the confounders of the relation between alco-
hol consumption and peripheral arterial disease. Because
measurement of the ankle/brachial blood pressure index was
performed only on noninstitutionalized subjects who visited
the research center and because participants with dementia
were not interviewed about their diet, our subjects were 
relatively healthy and mobile. They may not be a represen-
tative sample of the whole elderly population without preva-
lent symptomatic cardiovascular disease.
Only a few other studies have investigated the association
of alcohol consumption with the presence of peripheral ath-
erosclerosis. Jepson et al. (13) found in the Edinburgh Artery
Study a higher ankle/brachial blood pressure index (thus less
peripheral arterial disease) in men with high alcohol con-
sumption but no association in women. The ankle/brachial
blood pressure index was associated with wine consumption
but not with beer or liquor consumption. After additional
adjustment for social class the positive associations disap-
peared, possibly indicating confounding by social class. The
findings for women in this study were considered the result
of the relatively low consumption of alcohol in this group
(median consumption of one drink per week). In the prospec-
tive Physicians’ Health Study, the relative risk of sympto-
matic peripheral arterial disease associated with moderate
alcohol use was 0.74 in multivariate analysis (15). This
cohort comprised subjects who were on average 10 years
younger and had a higher average educational level than the
men in our study. Furthermore, the overall alcohol consump-
tion was very low in comparison with our study and other
studies: 97 percent of the men reported use of less than two
drinks a day. The consumption of different types of alcoholic
beverages was not taken into account in this study. The
Framingham Heart Study found the lowest risk of intermit-
tent claudication at levels of 13–24 g of alcohol per day in
men (hazard ratio  0.67, 95 percent CI: 0.42, 0.99) and
7–12 g in women (hazard ratio  0.44, 95 percent CI: 0.23,
0.80), compared with nondrinkers (16). Beer and wine espe-
cially were negatively associated with the occurrence of
intermittent claudication. The study population, although
younger than our population, had a distribution of alcohol
consumption similar to ours. In this study and the
Physicians’ Health study, only subjects with an onset of inter-
mittent claudication or peripheral arterial surgery were 
considered peripheral arterial disease cases. Alcohol may
influence the clinical symptoms of peripheral arterial disease
by preferentially dilating diseased arteries (16). In a study
among American Indians, a study population with fewer
cases of peripheral arterial disease than ours, a statistically
significant inverse association between alcohol drinking and
peripheral arterial disease was found in multiple logistic
regression analysis. However, there was no information on
the types and amount of alcohol consumed (14).
We found an inverse association between alcohol con-
sumption and peripheral arterial disease for women but not
for men. Because of the small range of alcohol intake among
women, with only 10 percent consuming over 20 g of alco-
hol daily, it was not possible to examine the risk of periph-
eral arterial disease in heavy-drinking women. Although the
range of alcohol consumption among men was wider, the
odds ratio of peripheral arterial disease was not significantly
different from one for any of the alcohol consumption cate-
gories compared with nondrinking. Part of the gender dif-
ference may be explained by a strong confounding effect of
smoking. In nonsmoking subjects, an inverse association
between alcohol consumption and peripheral arterial disease
was present in both men and women. The inverse associa-
tion was strongest in never-smoking women. Unfortunately,
we were not able to study the association between alcohol
consumption and peripheral arterial disease in never-
smoking men because of small numbers. In our population,
only 8 percent of men had never smoked. The percentage of
never-smoking men was higher in the Edinburgh Artery
Study (25 percent) and in the Physicians’ Health Study (50
percent). The effect of smoking may have been less distort-
ing in these studies. Furthermore, the discrepancy concern-
ing the observed associations for men and women can 
possibly be explained in part by differences in the distribu-
tion of the beverage types consumed. In our study popula-
tion women consumed mainly wine and fortified wine types,
and we found the association to be strongest for these alco-
holic beverages. The inverse association of wine consump-
tion and peripheral arterial disease is in concordance with
results from the Edinburgh Artery Study (13). Contrary to
their results, the associations we found remained after addi-
tional adjusting for social class. Although our data for men
are not incompatible with an effect of wine, the association
was weak and not significant. Furthermore, because of small
numbers of cases among beer drinkers and liquor drinkers in
women, possible inverse associations between these bever-
ages and peripheral arterial disease cannot be excluded.
An extensive review on alcohol and risk of coronary
heart disease concluded that there is strong evidence that
beer, liquor, and wine are all three associated with a lower
risk of coronary heart disease (26). The review focused pri-
marily on the acute events of coronary atherosclerotic dis-
ease, in which clotting and fibrinolysis are also thought to
play a major role. We studied the long-term process of
atherogenesis, in which the effect of alcoholic beverages on
atherosclerosis is more important. Alcohol itself affects
hemostasis (27) and affects atherosclerosis through its
effect on the lipid profile (28). Possibly additional effects
on atherosclerosis may be mediated by substances present
only in wines. Wine and fortified wines contain phenolic
substances, which have been shown to have antioxidant
effects on low-density lipoproteins, thus decelerating
atherogenesis (29, 30).
In summary, in this large population-based study moder-
ate alcohol consumption was inversely associated with
peripheral arterial disease in women but not in men.
Residual confounding by smoking may have influenced the
results. Among nonsmokers an inverse association was
found between alcohol consumption and peripheral arterial
disease in both men and women.
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